Cardiovascular Health and Protection Against CVD
2014; Lippincott Williams & Wilkins; Volume: 130; Issue: 19 Linguagem: Inglês
10.1161/circulationaha.114.012869
ISSN1524-4539
Autores Tópico(s)Cardiac Health and Mental Health
ResumoHomeCirculationVol. 130, No. 19Cardiovascular Health and Protection Against CVD Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBCardiovascular Health and Protection Against CVDMore Than the Sum of the Parts? Donald M. Lloyd-Jones, MD, ScM, FAHA Donald M. Lloyd-JonesDonald M. Lloyd-Jones From the Department of Preventive Medicine and the Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Originally published1 Oct 2014https://doi.org/10.1161/CIRCULATIONAHA.114.012869Circulation. 2014;130:1671–1673Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: November 4, 2014: Previous Version 1 Five years ago, the American Heart Association (AHA) launched a bold new initiative to begin promoting "cardiovascular health" in individuals and the population, in addition to continuing its decades-long fight to reduce cardiovascular and stroke mortality and decrease cardiovascular disease (CVD) risk. This shift in priorities came as a result of a "quiet revolution,"1 turning the adverse-outcomes-oriented and risk-focused perspective on its head, and instead focusing on creating the opportunity for promoting and preserving attributes associated with healthy, CVD-free longevity. The first-ever formal definition for this construct of cardiovascular health, published in 2010,2 was based on a broad review of the literature designed to determine groups of factors associated with excellent prognosis in long-term CVD-free survival and quality of life. It was designed to be simple, accessible, and actionable, allowing all patients, clinicians, and communities to focus on improving cardiovascular health. And it was crafted in a way so that it could be measured in the broad US population and major subgroups, monitored over time, and influenced by the AHA portfolio of programs.2 Although the entire spectrum of cardiovascular health was captured (from birth through living with CVD), a critical observation was the recognition of an "ideal cardiovascular health" phenotype that consisted of the simultaneous presence of ideal levels of 7 health behaviors and health factors: smoking status, physical activity, eating pattern, body weight, and blood cholesterol, blood glucose, and blood pressure levels.Article see p 1676In the 5 years since publication of the definition of cardiovascular health, numerous investigators have examined the prevalence of levels of ideal cardiovascular health in diverse populations from around the globe.3–8 In countries with more developed economies, it seems to be a universal finding that the prevalence of truly ideal cardiovascular health in adults is rare (often 60 years of age.9 Recent data suggest that this is much more a function of the loss of healthy lifestyle and behavior attributes during young adulthood rather than an inevitable consequence of aging or heredity. There are even positive indications that improving lifestyle can make a large difference in preserving ideal cardiovascular health, that small changes can have an impact, and that it is never too late, although earlier implementation is clearly better.10–12A number of studies have also examined the prospective associations of different levels of cardiovascular health with short-term and long-term cardiovascular and noncardiovascular outcomes. Table 1 provides a summary of the outcomes favorably associated with greater cardiovascular health to date. Findings have consistently demonstrated that having more of the 7 components at ideal levels is associated with lower risk for fatal and nonfatal cardiovascular events in all race/sex subgroups studied, with extremely low incidence rates in those with ideal cardiovascular health (ie, all 7 metrics at ideal levels). Intriguing data also reveal associations with lower risk for incident cancer, better cognition in younger and older adults, less depression, better quality of life, enhanced compression of morbidity, and even lower healthcare charges, among other outcomes.4,7,13–18 It is certainly intuitive that lower levels of cardiovascular risk factors and better health behaviors should be associated with lower risk for CVD. And yet, one of the tantalizing impressions when one examines data on this ideal cardiovascular health concept is that the whole may indeed be greater than the sum of the parts.Table. Domains of Improved Outcomes With Which Greater Levels of Cardiovascular Health (as defined by the American Heart Association)2 Have Been Associated ProspectivelyAll-Cause (total) MortalityEnd-Stage Renal Disease CVD, coronary, stroke mortalityAtherosclerosis and arterial stiffness in younger adultsNonfatal CVD eventsCognitive function in younger and older adults Coronary heart diseaseDepression StrokeQuality of lifeIncident cancerCompression of morbidityVenous thromboembolismMedicare chargesCVD indicates cardiovascular disease.In this issue of Circulation, Xanthakis et al19 from the Framingham investigators provide the latest pieces of evidence linking greater cardiovascular health to favorable outcomes with regard to CVD incidence. The major contribution these authors make is in filling some of the gaps in our understanding about the mechanisms underlying the association of greater cardiovascular health with lower disease incidence. One may legitimately ask: Do people with better cardiovascular health simply develop less subclinical disease (atherosclerosis or vascular or myocardial damage) over time and therefore they are at lower CVD risk just because of that? Or is there possibly more to it?Xanthakis et al characterized 2680 mostly middle-aged Framingham Study participants with regard to their cardiovascular health status on all 7 metrics at baseline. Consistent with the approach taken by many other investigators, they created a simple score from 0 to 7 points indicating how many cardiovascular health metrics each participant had at ideal levels. They then examined associations of the score with various serological markers of inflammation, coagulation, and target-organ damage, as well as measures of subclinical CVD, including increased carotid intima-media thickness or stenosis, evidence of left ventricular hypertrophy or systolic dysfunction, microalbuminuria, or low ankle-brachial index. As expected, on average, most of the serum biomarkers were within normative ranges in this sample. Having a higher cardiovascular health score was significantly associated with modestly lower levels of aldosterone, C-reactive protein, D-dimer, fibrinogen, growth-differentiation factor 15, homocysteine, and plasminogen activator-inhibitor 1. In other words, greater cardiovascular health was associated with lower levels of adverse biomarkers. An interesting finding was a positive association of the cardiovascular health score with natriuretic peptide levels within the normative range, which the authors plausibly suggest may be attributable to enrichment of the sample at higher scores for those with lower body mass index, as well more women, 2 factors associated with higher natriuretic peptide levels.19A higher cardiovascular health score was also associated with lower odds of having subclinical disease. For each 1 point higher in the score, the odds of having any subclinical disease measure were 23% lower. Higher scores were even less likely to be associated with evidence for multiple aspects of subclinical disease. Therefore, it may come as no surprise that Xanthakis et al observed a significantly lower risk for CVD events (coronary heart disease, stroke or transient ischemic attack, heart failure, or claudication) among those with higher cardiovascular health scores, with a hazard ratio of 0.77 per 1-point higher on the cardiovascular health score and a generally linear relationship across the range of scores.19 In this study, compared with someone with 0 points, someone with 1 point was, on average, at 23% lower risk for CVD over 16 years; someone with 2 points was at 41% [1-(0.77×0.77] lower risk; and so on.However, the innovative aspect of the authors' analysis is that they then adjusted for the significant biomarkers and subclinical disease measures, which might be expected to completely attenuate the association between the cardiovascular health score and incident CVD because they represent likely intermediary factors in the pathway from cardiovascular health to disease. But even after adjustment for the biomarkers and subclinical disease measures, the cardiovascular health score remained independently and significantly associated with lower risk for CVD (hazard ratio, 0.87; 95% confidence interval, 0.78 – 0.97 for each 1 point higher in the score).What are we to make of this? To be sure, we must be cautious and recognize the potential for residual confounding. The vast majority of CVD events are of course preceded by evidence of vascular or myocardial alterations or damage, and the measures available to the authors for this analysis incompletely represent all of the causal pathways involved in the transition from cardiovascular health to CVD. Nonetheless, the Framingham investigators have provided the most interesting data to date examining potential mechanisms underlying the construct of cardiovascular health. Their data suggest that there might be additional intangible benefits of the cardiovascular health phenotype, perhaps related to other aspects of a healthy lifestyle, or the tendency for longer exposure to favorable levels of cardiovascular health metrics among those with greater cardiovascular health (because it is easier and more common to preserve it than restore it).Such speculations require further investigation. In the meantime, these data provide even more strong and compelling evidence that, regardless of the mechanism, promotion of cardiovascular health must be advanced immediately and forcefully as a key part of the national agenda at every level of policymaking, across all healthcare and public health systems, and for all segments of the population. Only with maximal effort can we blunt the substantial burden of CVD and CVD-related costs that are impending over the next decades.20 To promote and achieve a culture of health in which all Americans, and particularly our youth, can achieve healthy longevity, where cardiovascular health is poor, we must improve it; where it is intermediate, we must restore it; and where ideal, we must preserve it.DisclosuresNone.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to Donald M. Lloyd-Jones, MD, ScM, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, 680 N Lake Shore Dr, Suite 1400, Chicago, IL 60611. E-mail [email protected]References1. Labarthe DR. From cardiovascular disease to cardiovascular health: a quiet revolution?Circ Cardiovasc Qual Outcomes. 2012; 5:e86–e92.LinkGoogle Scholar2. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.Circulation. 2010; 121:586–613.LinkGoogle Scholar3. Del Brutto OH, Dong C, Rundek T, Elkind MS, Del Brutto VJ, Sacco RL. Cardiovascular Health Status Among Caribbean Hispanics Living in Northern Manhattan and Ecuadorian Natives/Mestizos in Rural Coastal Ecuador.J Community Health. 2013; 38:634–641.CrossrefMedlineGoogle Scholar4. Laitinen TT, Pahkala K, Magnussen CG, Viikari JS, Oikonen M, Taittonen L, Mikkila V, Jokinen E, Hutri-Kahonen N, Laitinen T, Kahonen M, Lehtimaki T, Raitakari OT, Juonala M. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood.Circulation. 2012; 125:1971–1978.LinkGoogle Scholar5. Shay CM, Ning H, Allen NB, Carnethon MR, Chiuve SE, Greenlund KJ, Daviglus ML, Lloyd-Jones DM. Status of cardiovascular health in US adults.Circulation. 2012; 125:45–56.LinkGoogle Scholar6. Vetrano DL, Martone AM, Mastropaolo S, Tosato M, Colloca G, Marzetti E, Onder G, Bernabei R, Landi F. Prevalence of the seven cardiovascular health metrics in a Mediterranean country: results from a cross-sectional study.Eur J Public Health. 2013; 23:858–862.CrossrefMedlineGoogle Scholar7. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults.JAMA. 2012; 307:1273–1283.CrossrefMedlineGoogle Scholar8. Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, Li N, Bian L, Wu J, Jia Q, Wu S, Zhao X. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke.Stroke. 2013; 44:2451–2456.LinkGoogle Scholar9. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics–2012 update.Circulation. 2012; 125:e2–e220.LinkGoogle Scholar10. Liu K, Daviglus ML, Loria CM, Colangelo LA, Spring B, Moller AC, Lloyd-Jones DM. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age.Circulation. 2012; 125:996–1004.LinkGoogle Scholar11. Spring B, Moller AC, Colangelo LA, Siddique J, Roehrig M, Daviglus ML, Polak JF, Reis JP, Sidney S, Liu K. Healthy lifestyle change and subclinical atherosclerosis in young adults.Circulation. 2014; 130:10–17.LinkGoogle Scholar12. Laitinen TT, Pahkala K, Venn A, Woo JG, Oikonen M, Dwyer T, Mikkila V, Hutri-Kahonen N, Smith KJ, Gall SL, Morrison JA, Viikari JS, Raitakari OT, Magnussen CG, Juonala M. Childhood lifestyle and clinical determinants of adult ideal cardiovascular health.Int J Cardiol. 2013; 169:126–132.CrossrefMedlineGoogle Scholar13. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics.Circulation. 2012; 125:2975–2984.LinkGoogle Scholar14. Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD; ARIC Study Investigators. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence.J Am Coll Cardiol. 2011; 57:1690–1696.CrossrefMedlineGoogle Scholar15. Kulshreshtha A, Vaccarino V, Judd SE, Howard VJ, McClellan WM, Muntner P, Hong Y, Safford MM, Goyal A, Cushman M. Life's Simple 7 and risk of incident stroke.Stroke. 2013; 44:1909–1914.LinkGoogle Scholar16. Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, Folsom AR. Ideal cardiovascular health is inversely associated with incident cancer.Circulation. 2013; 127:1270–1275.LinkGoogle Scholar17. Reis JP, Loria CM, Launer LJ, Sidney S, Liu K, Jacobs DR, Zhu N, Lloyd-Jones DM, He K, Yaffe K. Cardiovascular health through young adulthood and cognitive functioning in midlife.Ann Neurol. 2013; 73:170–179.CrossrefMedlineGoogle Scholar18. Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM. Lifetime risk and years lived free of total cardiovascular disease.JAMA. 2012; 308:1795–1801.CrossrefMedlineGoogle Scholar19. Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.Circulation. 2014; 130:1676–1683.LinkGoogle Scholar20. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association.Circulation. 2011; 123:933–944.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Douglas P, McCallum S, Lu M, Umbleja T, Fitch K, Foldyna B, Zanni M, Fulda E, Bloomfield G, Fichtenbaum C, Overton E, Aberg J, Malvestutto C, Burdo T, Arduino R, Ho K, Yin M, Ribaudo H and Grinspoon S (2022) Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV, AIDS, 10.1097/QAD.0000000000003418, 37:3, (423-434), Online publication date: 1-Mar-2023. Kaufeld T, Erik B, Linda R, Heike K, Ruslan N, Morsi A, Wilhelm K, Tobias S, Axel H, Axel M and Malakh S (2023) Preoperative pericardial hematoma in patients with acute type A aortic dissection (AAAD): Do we need an adjusted treatment?, Journal of Cardiothoracic Surgery, 10.1186/s13019-023-02152-1, 18:1 Makarem N, Castro‐Diehl C, St‐Onge M, Redline S, Shea S, Lloyd‐Jones D, Ning H and Aggarwal B (2022) Redefining Cardiovascular Health to Include Sleep: Prospective Associations With Cardiovascular Disease in the MESA Sleep Study, Journal of the American Heart Association, 11:21, Online publication date: 1-Nov-2022. Trudel-Fitzgerald C, Chen R, Lee L and Kubzansky L (2022) Are coping strategies and variability in their use associated with lifespan?, Journal of Psychosomatic Research, 10.1016/j.jpsychores.2022.111035, 162, (111035), Online publication date: 1-Nov-2022. Lloyd-Jones D, Allen N, Anderson C, Black T, Brewer L, Foraker R, Grandner M, Lavretsky H, Perak A, Sharma G and Rosamond W (2022) Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association, Circulation, 146:5, (e18-e43), Online publication date: 2-Aug-2022. Nappi F, Iervolino A and Avtaar Singh S (2022) Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes, Biomedicines, 10.3390/biomedicines10020437, 10:2, (437) Freundt M, Kolat P, Friedrich C, Salem M, Gruenewald M, Elke G, Pühler T, Cremer J and Haneya A (2021) Preoperative Predictors of Adverse Clinical Outcome in Emergent Repair of Acute Type A Aortic Dissection in 15 Year Follow Up, Journal of Clinical Medicine, 10.3390/jcm10225370, 10:22, (5370) Krefman A, Labarthe D, Greenland P, Pool L, Aguayo L, Juonala M, Kähönen M, Lehtimäki T, Day R, Bazzano L, Muggeo V, Van Horn L, Liu L, Webber L, Pahkala K, Laitinen T, Raitakari O, Lloyd-Jones D and Allen N (2021) Influential Periods in Longitudinal Clinical Cardiovascular Health Scores, American Journal of Epidemiology, 10.1093/aje/kwab149, 190:11, (2384-2394), Online publication date: 2-Nov-2021. Manolis T, Manolis A, Apostolopoulos E, Melita H and Manolis A Cardiovascular Complications of Sleep Disorders: A Better Night's Sleep for a Healthier Heart / From Bench to Bedside, Current Vascular Pharmacology, 10.2174/1570161118666200325102411, 19:2, (210-232) Trudel-Fitzgerald C, Zevon E, Kawachi I, Tucker-Seeley R, Grodstein F, Kubzansky L and Martire L (2019) The Prospective Association of Social Integration With Life Span and Exceptional Longevity in Women, The Journals of Gerontology: Series B, 10.1093/geronb/gbz116, 75:10, (2132-2141), Online publication date: 13-Nov-2020. Makarem N, Sears D, St-Onge M, Zuraikat F, Gallo L, Talavera G, Castaneda S, Lai Y, Mi J and Aggarwal B (2020) Habitual Nightly Fasting Duration, Eating Timing, and Eating Frequency are Associated with Cardiometabolic Risk in Women, Nutrients, 10.3390/nu12103043, 12:10, (3043) Boehm J, Qureshi F, Chen Y, Soo J, Umukoro P, Hernandez R, Lloyd-Jones D and Kubzansky L (2020) Optimism and Cardiovascular Health: Longitudinal Findings From the Coronary Artery Risk Development in Young Adults Study, Psychosomatic Medicine, 10.1097/PSY.0000000000000855, 82:8, (774-781), Online publication date: 1-Oct-2020. Osazuwa‐Peters O, Waken R, Schwander K, Sung Y, de Vries P, Hartz S, Chasman D, Morrison A, Bierut L, Xiong C, de las Fuentes L and Rao D (2020) Identifying blood pressure loci whose effects are modulated by multiple lifestyle exposures, Genetic Epidemiology, 10.1002/gepi.22292, 44:6, (629-641), Online publication date: 1-Sep-2020. Boehm J, Chen Y, Qureshi F, Soo J, Umukoro P, Hernandez R, Lloyd-Jones D and Kubzansky L (2020) Positive emotions and favorable cardiovascular health: A 20-year longitudinal study, Preventive Medicine, 10.1016/j.ypmed.2020.106103, 136, (106103), Online publication date: 1-Jul-2020. Ruiz-Estigarribia L, Martínez-González M, Díaz-Gutiérrez J, Sayón-Orea C, Basterra-Gortari F and Bes-Rastrollo M (2020) Lifestyle behavior and the risk of type 2 diabetes in the Seguimiento Universidad de Navarra (SUN) cohort, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2020.04.006, 30:8, (1355-1364), Online publication date: 1-Jul-2020. Maclean E, Yap J, Saberwal B, Kolvekar S, Lim W, Wijesuriya N, Papageorgiou N, Dhillon G, Hunter R, Lowe M, Lambiase P, Chow A, Abbas H, Schilling R, Rowland E and Ahsan S (2020) The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: A single centre, propensity-matched cohort study, International Journal of Cardiology, 10.1016/j.ijcard.2019.10.053, 303, (49-53), Online publication date: 1-Mar-2020. Perak A, Ning H, Khan S, Van Horn L, Grobman W and Lloyd‐Jones D (2020) Cardiovascular Health Among Pregnant Women, Aged 20 to 44 Years, in the United States, Journal of the American Heart Association, 9:4, Online publication date: 18-Feb-2020. Colca J (2020) NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root, Expert Opinion on Investigational Drugs, 10.1080/13543784.2020.1715940, 29:2, (191-196), Online publication date: 1-Feb-2020. Makarem N, St-Onge M, Liao M, Lloyd-Jones D and Aggarwal B (2019) Association of sleep characteristics with cardiovascular health among women and differences by race/ethnicity and menopausal status: findings from the American Heart Association Go Red for Women Strategically Focused Research Network, Sleep Health, 10.1016/j.sleh.2019.05.005, 5:5, (501-508), Online publication date: 1-Oct-2019. Schiman C, Liu L, Shih Y, Zhao L, Daviglus M, Liu K, Fries J, Garside D, Vu T, Stamler J, Lloyd-Jones D and Allen N (2019) Cardiovascular health in young and middle adulthood and medical care utilization and costs at older age – The Chicago Heart Association Detection Project Industry (CHA), Preventive Medicine, 10.1016/j.ypmed.2018.12.024, 119, (87-98), Online publication date: 1-Feb-2019. Kevany K, Baur G and Wang G (2018) Shifting Food Systems: Increasing Well-Being Through Plant-Based Approaches, EXPLORE, 10.1016/j.explore.2018.04.012, 14:6, (435-442), Online publication date: 1-Nov-2018. Winning A, McCormick M, Glymour M, Gilsanz P and Kubzansky L (2018) Childhood Psychological Distress and Healthy Cardiovascular Lifestyle 17–35 Years Later: The Potential Role of Mental Health in Primordial Prevention, Annals of Behavioral Medicine, 10.1093/abm/kax001, 52:8, (621-632), Online publication date: 13-Jul-2018. Thiriet M (2018) Cardiovascular Risk Factors and Markers Vasculopathies, 10.1007/978-3-319-89315-0_2, (91-198), . Lane-Cordova A, Kershaw K, Liu K, Herrington D and Lloyd-Jones D (2017) Association Between Cardiovascular Health and Endothelial Function With Future Erectile Dysfunction: The Multi-Ethnic Study of Atherosclerosis, American Journal of Hypertension, 10.1093/ajh/hpx060, 30:8, (815-821), Online publication date: 1-Aug-2017. Polonsky T, Ning H, Daviglus M, Liu K, Burke G, Cushman M, Eng J, Folsom A, Lutsey P, Nettleton J, Post W, Sacco R, Szklo M and Lloyd‐Jones D (2017) Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi‐Ethnic Study of Atherosclerosis, Journal of the American Heart Association, 6:3, Online publication date: 1-Mar-2017. Foraker R, Shoben A, Kelley M, Lai A, Lopetegui M, Jackson R, Langan M and Payne P (2016) Electronic health record-based assessment of cardiovascular health: The stroke prevention in healthcare delivery environments (SPHERE) study, Preventive Medicine Reports, 10.1016/j.pmedr.2016.07.006, 4, (303-308), Online publication date: 1-Dec-2016. Roth C, Payne P, Weier R, Shoben A, Fletcher E, Lai A, Kelley M, Plascak J and Foraker R (2016) The geographic distribution of cardiovascular health in the stroke prevention in healthcare delivery environments (SPHERE) study, Journal of Biomedical Informatics, 10.1016/j.jbi.2016.01.013, 60, (95-103), Online publication date: 1-Apr-2016. Davies J, Delfino S, Feinberg C, Johnson M, Nappi V, Olinger J, Schwab A and Swanson H (2016) Current and Emerging Uses of Statins in Clinical Therapeutics: A Review, Lipid Insights, 10.4137/LPI.S37450, 9, (LPI.S37450), Online publication date: 1-Jan-2016. Vahedian Z, Amini H, Tehrani M, Zarei R, Moghimi S, Mozaffarieh M and Fakhraie G (2015) Retinal venous pressure in chronic smokers, EPMA Journal, 10.1186/s13167-015-0031-5, 6:1, Online publication date: 1-Dec-2015. Macaluso S, Marcus A, Rigassio-Radler D, Byham-Gray L and Touger-Decker R (2015) Increased Physical Activity Leads to Improved Health-Related Quality of Life Among Employees Enrolled in a 12-Week Worksite Wellness Program, Journal of Occupational & Environmental Medicine, 10.1097/JOM.0000000000000545, 57:11, (1214-1221), Online publication date: 1-Nov-2015. Shay C, Gooding H, Murillo R and Foraker R (2015) Understanding and Improving Cardiovascular Health: An Update on the American Heart Association's Concept of Cardiovascular Health, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2015.05.003, 58:1, (41-49), Online publication date: 1-Jul-2015. Antman E (2015) Saving and Improving Lives in the Information Age, Circulation, 131:25, (2238-2242), Online publication date: 1-Jun-2015.Fonarow G, Calitz C, Arena R, Baase C, Isaac F, Lloyd-Jones D, Peterson E, Pronk N, Sanchez E, Terry P, Volpp K and Antman E (2015) Workplace Wellness Recognition for Optimizing Workplace Health, Circulation, 131:20, (e480-e497), Online publication date: 19-May-2015. November 4, 2014Vol 130, Issue 19 Advertisement Article InformationMetrics © 2014 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.114.012869PMID: 25273999 Originally publishedOctober 1, 2014 Keywordsrisk factorhealth statuscardiovascular outcomesEditorialsPDF download Advertisement SubjectsEpidemiology
Referência(s)